446 related articles for article (PubMed ID: 22641398)
1. Genetic modifiers of sickle cell disease.
Steinberg MH; Sebastiani P
Am J Hematol; 2012 Aug; 87(8):795-803. PubMed ID: 22641398
[TBL] [Abstract][Full Text] [Related]
2. Genetic etiologies for phenotypic diversity in sickle cell anemia.
Steinberg MH
ScientificWorldJournal; 2009 Jan; 9():46-67. PubMed ID: 19151898
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the phenotypic diversity of sickle cell anemia.
Steinberg MH
Hemoglobin; 1996 Feb; 20(1):1-19. PubMed ID: 8745428
[TBL] [Abstract][Full Text] [Related]
4. [Genetic modifiers of homozygous sickle cell disease].
Hartmann K; Kulozik AE
Klin Padiatr; 2006; 218(3):170-3. PubMed ID: 16688674
[TBL] [Abstract][Full Text] [Related]
5. Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease.
Thein SL
Adv Exp Med Biol; 2017; 1013():27-57. PubMed ID: 29127676
[TBL] [Abstract][Full Text] [Related]
6. Minireview: Genetic basis of heterogeneity and severity in sickle cell disease.
Habara A; Steinberg MH
Exp Biol Med (Maywood); 2016 Apr; 241(7):689-96. PubMed ID: 26936084
[TBL] [Abstract][Full Text] [Related]
7. Co-Inheritance of alpha-thalassemia and sickle cell disease in a cohort of Angolan pediatric patients.
Santos B; Delgadinho M; Ferreira J; Germano I; Miranda A; Arez AP; Faustino P; Brito M
Mol Biol Rep; 2020 Jul; 47(7):5397-5402. PubMed ID: 32632780
[TBL] [Abstract][Full Text] [Related]
8. Fetal hemoglobin and alpha thalassemia modulate the phenotypic expression of HbSD-Punjab.
Patel DK; Purohit P; Dehury S; Das P; Dutta A; Meher S; Patel S; Bag S; Mashon RS; Das K
Int J Lab Hematol; 2014 Aug; 36(4):444-50. PubMed ID: 24245819
[TBL] [Abstract][Full Text] [Related]
9. Combined and differential effects of alpha-thalassemia and HbF-quantitative trait loci in Senegalese hydroxyurea-free children with sickle cell anemia.
Gueye Tall F; Martin C; Ndour EHM; Renoux C; Ly ID; Connes P; Gueye PM; Diallo RN; Diagne I; Diop PA; Cissé A; Lopez Sall P; Joly P
Pediatr Blood Cancer; 2019 Oct; 66(10):e27934. PubMed ID: 31322815
[TBL] [Abstract][Full Text] [Related]
10. HbF-promoting polymorphisms may specifically reduce the residual risk of cerebral vasculopathy in SCA children with alpha-thalassemia.
Joly P; Bonello-Palot N; Badens C; Pissard S; Chamouine A; Bernaudin F; Bertrand Y; Connes P; Renoux C
Clin Hemorheol Microcirc; 2021; 77(3):267-272. PubMed ID: 33216016
[TBL] [Abstract][Full Text] [Related]
11. Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island.
Muszlak M; Pissard S; Badens C; Chamouine A; Maillard O; Thuret I
Hemoglobin; 2015; 39(3):156-61. PubMed ID: 25806420
[TBL] [Abstract][Full Text] [Related]
12. Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis.
Kirkham JK; Estepp JH; Weiss MJ; Rashkin SR
JAMA Netw Open; 2023 Oct; 6(10):e2337484. PubMed ID: 37851445
[TBL] [Abstract][Full Text] [Related]
13. High fetal hemoglobin level is associated with increased risk of cerebral vasculopathy in children with sickle cell disease in Mayotte.
Chamouine A; Saandi T; Muszlak M; Larmaraud J; Lambrecht L; Poisson J; Balicchi J; Pissard S; Elenga N
BMC Pediatr; 2020 Jun; 20(1):302. PubMed ID: 32563256
[TBL] [Abstract][Full Text] [Related]
14. Do Alpha Thalassemia, Fetal Hemoglobin, and the UGT1A1 Polymorphism have an Influence on Serum Bilirubin Levels and Cholelithiasis in Patients with Sickle Cell Disease?
de Azevedo LA; Bonazzoni J; Wagner SC; Farias MG; Bittar CM; Daudt L; de Castro SM
Mol Diagn Ther; 2017 Aug; 21(4):437-442. PubMed ID: 28567595
[TBL] [Abstract][Full Text] [Related]
15. Sickle cell disease: a multigenic perspective of a single gene disorder.
Kutlar A
Hemoglobin; 2007; 31(2):209-24. PubMed ID: 17486504
[TBL] [Abstract][Full Text] [Related]
16. Genetic association studies in β-hemoglobinopathies.
Thein SL
Hematology Am Soc Hematol Educ Program; 2013; 2013():354-61. PubMed ID: 24319204
[TBL] [Abstract][Full Text] [Related]
17. Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.
Noguchi CT; Dover GJ; Rodgers GP; Serjeant GR; Antonarakis SE; Anagnou NP; Higgs DR; Weatherall DJ; Schechter AN
J Clin Invest; 1985 May; 75(5):1632-7. PubMed ID: 2581999
[TBL] [Abstract][Full Text] [Related]
18. Alpha thalassemia, but not β
Hatzlhofer BLD; Pereira-Martins DA; de Farias Domingos I; Arcanjo GDS; Weinhäuser I; Falcão DA; Farias ICC; de Freitas Batista JVG; Prado LPL; Oliveira JMF; Batista THC; Sobreira MJVC; de Santana RM; Araújo ABS; de Melo MA; de Ancântara BV; Coelho-Silva JL; de Moura Rafael ABL; de Lima Silva DM; Albuquerque FP; Santos MNN; Dos Anjos AC; Costa FF; da Silva Araújo A; Lucena-Araújo AR; Bezerra MAC
Ann Hematol; 2021 Apr; 100(4):921-931. PubMed ID: 33586016
[TBL] [Abstract][Full Text] [Related]
19. Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes.
Sheehan VA; Luo Z; Flanagan JM; Howard TA; Thompson BW; Wang WC; Kutlar A; Ware RE;
Am J Hematol; 2013 Jul; 88(7):571-6. PubMed ID: 23606168
[TBL] [Abstract][Full Text] [Related]
20. Sickle cell disease in Saudi Arabia: the Asian haplotype. Reflections on a meeting at Hofuf, September 2003.
Serjeant GR; Serjeant BE
Ann Saudi Med; 2004; 24(3):166-8. PubMed ID: 15307451
[No Abstract] [Full Text] [Related]
[Next] [New Search]
